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Abstract
Messenger RNA is modified by the addition of a 50 methylated cap structure, which protects
the transcript and recruits protein complexes that mediate RNA processing and/or the initia-
tion of translation. Two genes encoding mRNA cap methyltransferases have been identified
in T. brucei: TbCMT1 and TbCGM1. Here we analysed the impact of TbCMT1 gene deletion
on bloodstream form T. brucei cells. TbCMT1 was dispensable for parasite proliferation in in
vitro culture. However, significantly decreased parasitemia was observed in mice inoculated
with TbCMT1 null and conditional null cell lines. Using RNA-Seq, we observed that several
cysteine peptidase mRNAs were downregulated in TbCMT1 null cells lines. The cysteine
peptidase Cathepsin-L was also shown to be reduced at the protein level in TbCMT1 null
cell lines. Our data suggest that TbCMT1 is not essential to bloodstream form T. brucei
growth in vitro or in vivo but that it contributes significantly to parasite virulence in vivo.
Introduction
Trypanosoma brucei, a protozoan parasite transmitted by the tsetse fly, causes Human African
Trypanosomiasis (HAT) and Nagana in cattle [1]. When a tsetse fly feeds on infected human
or animal blood, stumpy form T. brucei trypomastigotes enter the insect midgut and differenti-
ate into the proliferating procyclic form (PCF) cells [2]. These migrate to the salivary glands
and differentiate into proliferating epimastigote form cells and finally into non-dividing ani-
mal-infective metacyclic trypomastigotes [3]. During a subsequent blood meal, the tsetse fly
transmits the metacyclic trypomastigotes into the hemolymphatic system of the host where
they transform into the rapidly proliferating slender bloodstream form (BSF), and the cycle of
infection begins again.
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T. brucei genes are arranged in polycistronic units. RNA Polymerase II (RNA Pol II) tran-
scribes protein-coding genes into polycistrons containing dozens of transcripts [4, 5]. These
polycistrons are unidirectional and partitioned by strand-switch regions (SSRs) that are char-
acterised by a stretch of G nucleotides between divergent stretches of genes. The processing of
the transcription unit occurs co-transcriptionally by trans-splicing coupled to cleavage of the
3’ end by the polyadenylation machinery for poly(A) addition [6]. During trans-splicing, a
capped 39-nucleotide (nt) spliced leader (SL), or mini-exon, is added to the 50 termini of
mRNAs [7]. This SL is independently transcribed from a tandem array of 140-nt SL RNA
genes [8]. In addition to acting as a splicing substrate for the excision of a mRNA from the pri-
mary transcript, the SL RNA also provides each protein-coding mRNA with a 50 cap structure.
In eukaryotic cells, the mRNA cap includes N-7-methylguanosine (m7G) linked to the first
transcribed nucleotide via a 5’ to 5’ triphosphate linkage [9]. Trypanosomatids exhibit addi-
tional unique processing of the first four transcribed nucleotides in a structure called cap4
[10]. In cap4, the first four nucleotides are modified by 20-O-ribose methylations as well as
additional base methylations on the first and fourth nucleotides, to create the structure
m7Gpppm62AmpAmpCmpm
3Um [8, 11].
The cap4 structure of SL RNA is required for trans-splicing and is therefore essential for the
production of mature mRNAs. The enzymes which catalyse cap formation in eukaryotes con-
sist of a triphosphatase and guanylyltransferase, which catalyse guanosine cap addition, and a
series of methyltransferases which methylate the guanosine cap and transcribed nucleotides.
In T. brucei, the guanylyltransferase (TbCE1), which transfers GMP to the diphosphate end of
RNA, had no noticeable effect on PCF T. brucei cell viability when downregulated by RNAi
[12, 13]. Two genes encoding N-7 guanosine cap methyltransferases have been identified in T.
brucei: TbCMT1 and TbCGM1.TbCMT1 is a monofunctional cap methyltransferase. TbCGM1
has cap methyltransferase activity and guanylyltransferase activity, which presumably compen-
sates when TbCE1 is suppressed [13–15]. Quantitative proteomics demonstrated that the
expression of TbCMT1 is equivalent in PCF and BSF life stages of T. brucei [16], and RNAi-
mediated suppression of TbCMT1 also did not result in a growth defect in PCF cells [13]. Here
we investigated the function of TbCMT1 in BSF cells.
Results
TbCMT1 is not required for Lister 427 BSF proliferation in vitro
To investigate the role of TbCMT1 in BSF cells, null and conditional-null mutants of TbCMT1
were generated in a Lister 427 BSF ‘single marker’ (SM) cell line. The SM cell line has been
genetically modified to express the tetracycline repressor protein (TetR) and T7 RNA polymer-
ase, both under G418 selection [17]. In this paper, we will refer to the SM cell line as wild type
(WT) cells. To make the tetracycline-inducible TbCMT1 conditional-null clones, the first
TbCMT1 allele was replaced with PAC to create a TbCMT1 heterozygote and an ectopic copy
of the TbCMT1 gene, fused to a C-terminal MYC3-tag, was subsequently introduced into the
rDNA locus under phleomycin selection using the pLew100 vector. Following induction with
tetracycline, the second TbCMT1 allele was replaced with HYG (Panel A in S1 Fig). The
TbCMT1 null clones were created by replacing the remaining TbCMT1 allele of the TbCMT1
heterozygote with an HYG gene by homologous recombination (S2 Fig). Samples of genomic
DNA of the mutant cell lines and their intermediates were analysed by Southern blot to con-
firm the loss of the endogenous TbCMT1 alleles and the correct genomic locations of the PAC
and HYG genes (Panel B in S1 Fig and S2 Fig).
The tetracycline-dependence of TbCMT1-MYC3 mRNA expression in the conditional null
cell line was analysed. After 24 h without tetracycline, less than 1% TbCMT1 transcript was
TbCMT1 is a virulence factor for bloodstream form Trypanosoma brucei
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detected by qRT-PCR compared to the cells grown in the presence of tetracycline (Fig 1A).
The rate of BSF cell proliferation was measured under permissive (plus tetracycline) and non-
permissive (minus tetracycline) conditions over ten days. Lack of TbCMT1-MYC3 transcrip-
tion slightly impaired cell proliferation, indicating that TbCMT1 is likely to be dispensable for
T. brucei survival in vitro (Fig 1B). However, since the fetal bovine serum used to culture the
WT cell line might contain traces of tetracycline or doxycycline, we decided to make TbCMT1
null mutants and determined their growth characteristics. As observed for the TbCMT1 condi-
tional null cell line, deletion of the TbCMT1 gene only slightly impaired cell proliferation in
culture (Fig 1C), confirming unambiguously that TbCMT1 is not essential for T. brucei survival
in vitro.
The absence of TbCMT1 expression reduces T. brucei Lister 427 BSF
proliferation in vivo
Deletion of some T. brucei genes can affect parasite growth in vivo but not in vitro [18, 19] and
vice versa [20, 21]. To determine the role of TbCMT1 in vivo, we investigated whether deletion
of this gene influences T. brucei parasitemia in mice. Mice were inoculated with WT cells,
three independent clones of TbCMT1 null cells, and a conditional null clone under-permissive
(i.e., with doxycycline in the drinking water) and non-permissive conditions. The conditional
null cells were fully activated with tetracycline in culture prior to their injection into mice.
Three days after infection, WT T. brucei had proliferated as expected while all three TbCMT1
null clones exhibited a significant reduction in proliferation (Fig 2). The TbCMT1 conditional
null cells were similarly defective in proliferation in the absence, but not in the presence, of
doxycycline (Fig 2). Taken together, these data show that the absence of TbCMT1 expression
significantly reduces the rate of growth of bloodstream form T. brucei in vivo.
RNA-seq analysis
The mRNA cap and mRNA cap methyltransferases have been demonstrated to influence
many processes in gene expression including transcription, RNA stability, RNA processing
and initiation of translation. In human cells, a reduction in N-7 cap methylation has been dem-
onstrated to have a gene-specific impact on transcript and protein levels [22, 23]. For this rea-
son, we investigated the impact of TbCMT1 deletion on the transcriptome. RNA was extracted
from four independent WT and TbCMT1 null mutant cell cultures and analysed by Illumina
RNA sequencing. The WT and TbCMT1 null biological replicates showed pairwise Pearson
correlation coefficients >0.9 (S3 Fig). Principal component analysis (PCA) was used to evalu-
ate the variance between each biological replicate (S4 Fig) and this showed good separation of
the WT and TbCMT1 null biological replicates in the second principal component. For this
reason, all of the samples were used for the differential expression analysis, which revealed 86
differentially regulated genes with p-values <0.01 (S1 Table). Although at first inspection it
appeared that TbCMT1 (Tb927.10.4500) was only the second most downregulated transcript
upon TbCMT1 deletion, closer analysis of the RNA-seq coverage plot reveals that the sequence
reads assigned to the gene were from the 5’ and 3’ UTRs and not from the TbCMT1 open read-
ing frame, confirming deletion of both TbCMT1 alleles by homologous recombination via the
5’ and 3’ UTRs. Apart from TbCMT1 itself, the most downregulated (and several upregulated)
genes upon TbCMT1 deletion belong to the variant surface glycoprotein (VSG) family (S1
Table and Fig 3A). The most abundant and unchanged transcript is VSG MITat1.2 which is
the principal VSG expressed by the WT cell line used in these studies. However, antigenic vari-
ation (i.e., the switching of VSG gene expression) occurs stochastically and it is therefore per-
haps not surprising to see low abundance VSG transcripts going up and down between
TbCMT1 is a virulence factor for bloodstream form Trypanosoma brucei
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samples. Other than these, the main change was the downregulation of eleven transcripts of
the cysteine peptidase family. Since changes in transcript level are not always reflected in
changes at the protein level [24, 25], we investigated the protein level of the cysteine peptidase
cathepsin-L by Western blot in WT cells and three TbCMT1 null clones. Cathepsin-L protein
concentrations were consistently reduced by about 50% in the TbCMT1 null clones compared
to the WT cells (Fig 3B). A representative image of the Western blot analyses of Cathepsin-L
using HSP-70 as an internal control is provided in (S5 Fig).
Discussion
TbCMT1 null T. brucei Lister 427 BSF cells proliferated similarly to the parental cell line in tis-
sue culture. These findings are similar to the observation that RNAi-mediated knockdown of
TbCMT1 in T. brucei PCF cells also does not significantly impact cell growth [13]. This shows
that TbCMT1 is non-essential in culture. In contrast, deletion of TbCMT1 significantly
impacted parasitemia following mouse infection. Importantly, the proliferation defect of the
TbCMT1 conditional null cell line was rescued by the addition of doxycycline to the drinking
water of the infected mice, providing the crucial ‘add-back’ experiment. These data implicate
Fig 1. TbCMT1 is not required for T. brucei Lister 427 BSF proliferation in cell culture. (A) Total RNA was purified
from TbCMT1 conditional null cells cultured with (+tet) and without tetracycline for 24, 48 and 72 h. TbCMT1
expression was analysed by qRT-PCR normalised to telomerase reverse transcriptase (TERT). The delta Ct values (dCt)
for nine measurements for each condition are visualised as a swarm plot to show all observations along with
representations of the underlying distributions. (B) Cumulative cell counts of triplicate TbCMT1 conditional null
mutant cell cultures grown with (plus) and without (minus) tetracycline. (C) Cumulative cell counts of triplicate wild
type (WT) and TbCMT1null cells cultured in parallel. For the data in panels B and C, the cell counts of three biological
replicates are reported after 2, 4, 6, 8 and 10 days. The cultures were counted and diluted to 105 cells/ml every two days
in (B) and to 104 cells/ml every two days in (C). The cell counts are reported as the log10 value of the cumulative
number of parasites per ml of cell culture allowing for the aforementioned dilution factors.
https://doi.org/10.1371/journal.pone.0201263.g001
Fig 2. TbCMT1 is required for T. brucei proliferation in vivo. Mice were inoculated with wild type (WT) parasites,
three independent clones of TbCMT1 null mutants (null-1, null-2 and null-3), and a TbCMT1 conditional-null clone
(c-null). Mice receiving the latter were dosed with (+dox) or without (-dox) doxycycline in the drinking water for
seven days before and following inoculation. Blood parasitemias were measured in triplicate for each animal three days
after infection and a total of 14 (WT), 5 (null-1), 5 (null-2), 10 (null-3), 20 (c-null +dox) and 5 (c-null -dox) animals
were used. The parasitemia is reported as the number of parasites per ml of blood.
https://doi.org/10.1371/journal.pone.0201263.g002
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Fig 3. Differential gene expression analysis in wild type and TbCMT1null mutant cells. The figure shows the log10
transformation of the normalized mean for the transcript reads detected in the WT and TbCMT1null mutant samples
computed by DESeq2 (Base Mean, x axis) versus the log2 transformation of their mean fold change (y axis). A positive
fold change indicates transcript upregulation and a negative fold change indicates downregulation in the TbCMT1null
samples relative to WT. Highlighted with arrows are the top 5 up-regulated VSG-related transcripts (VSGs) and top 3
down-regulated cysteine peptidases transcripts (Cysteine Peptidases). The plot also highlights the position of the top
downregulated VSG transcript (VSG), the position of the downregulated TbCMT1 transcript (TbCMT1) and the
position of the unchanged MITat1.2 VSG transcript. (B) The plot shows the quantification of the Cathepsin-L protein
TbCMT1 is a virulence factor for bloodstream form Trypanosoma brucei
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TbCMT1 as a virulence gene for T. brucei in vivo, but not in vitro. Other examples of T. brucei
genes that exert their effects more profoundly in vivo than in vitro include the two oligosac-
charyltransferase genes, TbSTT3A and TbSTT3B, which are dispensable in tissue culture but
are essential in mouse infections [18] and these examples underline the need to determine
gene essentiality or virulence characteristics in vivo as well as in vitro.
With the aim of understanding the cellular functions affected by TbCMT1 deletion, we per-
formed RNA-Seq analyses of the transcriptomes of WT and TbCMT1 null mutants. The most
striking change was an approximately 2-fold downregulation of cysteine peptidase transcripts
in the TbCMT1 null mutants. The eleven T. brucei cysteine peptidase gene sequences are nearly
identical, such that the sequence mapping software distributes the transcript reads arbitrarily
to this group of genes. However, this reduction in transcript levels was mirrored at the protein
level as judged by quantitative Western blotting using anti-Cathepsin-L antibodies. The mech-
anism by which TbCMT1 deletion leads to the selective downregulation of cysteine peptidase
expression is unknown. Furthermore, for technical reasons, these data were collected from the
TbCMT1mutant grown in vitro and we cannot exclude the possibility that TbCMT1 deletion
has different effects in vivo.
Kinetoplastid parasites are known to have an abundance of cysteine peptidases that are
important for their survival in their hosts [26, 27]. Further, studies in Leishmania mexicana
have shown that cysteine peptidase-deficient amastigotes are infective in vitro but are signifi-
cantly impaired in infectivity in vivo [28, 29]. Thus, the observed selective downregulation in
cysteine peptidase transcript and protein levels in the TbCMT1mutants may explain their loss
of virulence in vivo, although we cannot exclude additional effects of removing TbCMT1 pro-
tein form the cells.
Material and methods
Cell culture
T. brucei BSF cells (strain 427, VSG variant MITaT 1.2) cells which expresses both T7 RNA poly-
merase and the Tetracycline repressor protein (TetR) under G418 selection [17] can be obtained
through BEI Resources, NIAID, NIH: Trypanosoma brucei subsp. brucei, Strain Lister 427 VSG
221 (TetR T7RNAP) (bloodstream form), NR-42011. These are referred to as ‘wild type’ trypano-
somes in this paper and were cultured at 37˚C with 5% CO2 in the presence of at 2.5 μg/ml G418
in cell culture flasks with filter lids (Greiner). Cells were grown to a maximum density of 3x106
cells/ml in HMI-9T medium. HMI-9T medium has the same formulation as HMI-9 medium
(Hirumi and Hirumi, 1994), with the exceptions that 56 μM 1-thioglycerol (Sigma) is used instead
of 200 μM 2-mercaptoethanol, and 2 mM GlutaMAX I (Gibco) was used instead of L-glutamine.
When required the following antibiotics were used for selection, 0.1 μg/ml Puromycin, 2.5 μg/ml
Phleomycin and 4 μg/ml Hygromycin. For conditional null mutant cultures, 0.5 μg /ml tetracy-
cline was used for permissive conditions. Growth curves were obtained by counting cells from
cultures using a CASY Cell Counter and Analyser Model TT (Innovatis, Roche).
Generation of gene replacement and ectopic copy constructs
The gene sequence for TbCMT1 (Tb927.10.4500) and its flanking regions was obtained from
TriTrypDB [30]. For TbCMT1 gene replacement by homologous recombination, about 500 bp
determined by quantitative Western blot in wild type (WT) and three TbCMT1null mutants clones (null-1, null-2 and
null-3). The values of the Cathepsin-L protein are normalized to the HSP-70 protein and divided by the value for the
WT sample.
https://doi.org/10.1371/journal.pone.0201263.g003
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of 5’- and 3’-UTR sequence were amplified by PCR from T. brucei genomic DNA. The seq-
uences of the primers to amplify the 5’ UTR were: ATA AGT ATG CGG CCG CGC ACT
CGC AGC GCT ATC CAG TTA TCC and GTT TAA ACT TAC GGA CCG TCA AGC TTT
AAG GTT ACG CTT TCA CCC CTT. The sequences of the primers to amplify the 3’ UTR
were: GAC GGT CCG TAA GTT TAA ACG GAT CCG GAG TAC TTA TCT CCC CGT
TTT C and ATA AGT AAG CGG CCG CGC TGG CAT ACA GGT GAC TGG CTT C. The
two PCR products were used together in a further PCR to yield a product containing the 5’-
UTR linked to the 3’-UTR by a HindIII, PmeI, BamHI cloning site (italic sequences) with NotI
sites at each end (underlined sequences). This was cloned into pGEM-5Zf and drug resistance
genes (HYG and PAC) were cloned into the HindII and BamHI sites as described previously
[25]. The constructs were verified by sequencing and digested with NotI, inactivated at 65˚C
for 30 min, ethanol precipitated overnight in -20˚C, washed in cold 70% ethanol and resus-
pended in sterile water, ready for electroporation. SM BSF cells were grown to mid-log phase
density at about 2x106 cells/ml, harvested and resuspended at 107 cells in 0.1 ml Amaxa
nucleofector II containing 1μg of digested and sterile construct DNA. Sometimes, Cytomix
solution (2 mM EGTA p.H. 7.6, 120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4/KH2PO4 pH
7.6, 25 mM HEPES pH 7.6, 5 mM MgCl2, 0.5% Glucose, 100 μg/ml defatted BSA, 1 mM Hypo-
xanthine) was utilized instead of Amaxa Nucleofactor for some electroporations. Control elec-
troporations without DNA were performed in parallel to verify antibiotic selection. Cells were
electroporated using Amaxa electroporator program X-001 [31] and subsequently recovered
in 12 ml HMI-9T without antibiotics for 14 h at 37˚C 5% CO2 before addition of 12 ml of
medium containing two-fold concentration of selection antibiotic (Puromycin or Hygromy-
cin). These cultures were plated in 12 well plates (2 ml per well) for selection and incubated at
37˚C plus 5% CO2. Antibiotic-resistant wells were cloned by dilution by plating into 96-well
plates at a concentration of 1 single cell/ml to ensure the resistant cells were clonal population.
Five clones of each electroporation were analysed by Southern blot [32]. To prepare the condi-
tional null mutant, before the second TbCMT1 allele was replaced, a tetracycline-inducible
ectopic copy of the TbCMT1 gene in the pLEW100 vector was introduced and induced. The
TbCMT1 open reading frame (ORF) was amplified with the primers: Forward ATA AGT ATC
ATA TGG AGA GCC TAC GGA CTG CAG C, Reverse ATA AGT AAC TCG AGC TGC
TGG CTT TCC GGA AGC ACA AC. The gene was amplified by PCR and cloned into pLEW
100-3xMYC [17]. The construct was verified by sequencing, electroporated, and recovered as
described above.
Southern blot analysis
Genomic DNA (gDNA, 5μg) was digested with restriction enzymes as indicated in S1 Fig and
S2 Fig, resolved by agarose gel electrophoresis and transferred onto positively charged Nylon
membrane using standard protocols. DNA probes were prepared using the PCR DIG Probe
Synthesis Kit (Roche). DIG probes were checked by agarose gel against non-Dig probes of
same sequence; if they showed increased size, they were presumed to be DIG labelled and used
in Southern hybridisation. Hybridisation and detection (by ECL) were performed according
to the manufacturer’s protocols.
qRT-PCR
RNA was extracted from log-phase cells using RNeasy Mini Extraction Kit (Qiagen). cDNA
was synthesised using the iScript cDNA Synthesis Kit (BioRad). qRT-PCR was performed
using Sybrgreen master mix (Bio-Rad) in a Bio-Rad iCycler Thermal Cycler.
TbCMT1 is a virulence factor for bloodstream form Trypanosoma brucei
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Growth curve analysis
Cell cultures were inoculated at 104 parasites/ml. The cultures were then counted using a
CASY cell counter and diluted to 104 cells/ml every two days for a total of 10 days. The cumu-
lative cell counts of three biological replicates for each condition are reported. For the condi-
tional null mutant, the cells were washed three times in HMI-9T minus tetracycline, diluted in
the same medium to 5x104 cells/ml and then cultured as described above plus and minus
0.5 μg/ml tetracycline.
Mouse infection studies
BALB/c female adult mice were obtained from Envigo International Ltd., Huntingdon, U.K.,
and were housed at 21˚C, 55–65% relative humidity with a 12 h / 12 h light / dark cycle. Groups
of mice were dosed for seven days with 0.2 mg/ml doxycycline in 5% sucrose or control 5%
sucrose in their drinking water prior to infection with T. brucei. Fresh drinking water solutions
were provided every 48 h. Prior to infection, wild-type, TbCMT1 null and TbCMT1 condi-
tional null mutants of bloodstream form trypanosomes were grown in HMI-9T media with
and without tetracycline then washed in media without antibiotics and resuspended at 1x106
cells/ml. Groups of 5 mice were used for each condition and each was injected intraperitone-
ally with 0.2 ml of cell suspension. Infections were assessed daily by tail bleeding and cell
counting was performed with a Neubauer chamber and a phase-contrast microscope.
RNA-seq analysis
Total RNA was isolated from T. brucei BSF followed by poly-A mRNA enrichment with strep-
tavidin poly-T oligo-attached magnetic beads (Dynabeads, Invitrogen). The mRNA was then
fragmented into 200 nt fragments using Covaris Adaptive Focused Acoustics process. Operat-
ing conditions—sample volume: 130 μl, duty cycle: 10%, intensity: 5, cycles per burst: 200, pro-
cessing time: 60 s, water bath temperature: 4˚C, power mode: frequency sweeping, degassing
mode: continuous. Fragmented mRNA was concentrated by ethanol precipitation and mea-
sured on an RNA Pico chip (Agilent 2100 bioanalyzer). The first strand of cDNA was synthe-
sised using reverse transcriptase and random primers, followed by second strand cDNA
synthesis which removes the RNA template producing double-stranded cDNA. To blunt-end
the DNA fragments, an end repair reaction was performed with Klenow polymerase, T4 DNA
polymerase, and T4 polynucleotide kinase. A single 3’ adenosine overhang was added to the
cDNA allowing the ligation of Illumina adaptors. These adaptors contain primer sites both for
sequencing and complimentary annealing onto the Illumina flowcell surface. Adaptor ligated
cDNA fragments were measured on an Agilent DNA chip. The final cDNA library was
sequenced on a MiSeq Personal Sequencer (Illumina). The fastq files were trimmed for adap-
tors and assessed for the quality score distribution with the FastQC program. Reads with an
average quality score less than 30 were removed from the analysis with a custom python script.
In order to align reads, a hybrid genome assembly consisting of the T. brucei 927 reference
genome (version 32.0) deposited at the TryTripDB database [30] and a list of 2563 distinct
genes encoding complete and partial VSG genes of the Lister 427 strain [33] was assembled.
The reads were aligned with bowtie2 v2.1.0 using the parameters—local—very-sensitive [34].
The Samtools package [35] was used to convert the sam files to bam files, and the Picard pack-
age was used to order the bam file by coordinate. The read count per gene was computed with
Rsubread with the options isPairedEnd = TRUE and requireBothEndsMapped = TRUE [36].
The differential gene expression analysis was carried out with DESeq2 [37]. The correlation
and principal component analysis were accomplished with Python using the scipy and scikit-
learn packages. The matplotlib and seaborn Python packages were used for visualizations. The
TbCMT1 is a virulence factor for bloodstream form Trypanosoma brucei
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dataset is deposited at the NCBI Sequence Read Archive with accession number SRX3923124
[38].
Quantitative Western blots
BSF cells were washed with cold PBS and lysed in reducing sample buffer (prepared as Invitro-
gen formulation but bromophenol Blue was replaced by 0.2% (W/V) Orange G, to reduce
Licor background, and containing 0.1 M final DTT). Samples (equivalent to 1x106 parasites)
were loaded into a pre-cast Novex 4–12% Bis-Tris gel and separated using 1x MOPS running
buffer (Invitrogen) for about 1 h at 200 V. Proteins were transferred onto nitrocellulose mem-
brane using iBLOT system (Invitrogen), program 3 for 7 minutes. Membranes were placed in
SNAPid cassette (Millipore) and blocked by filtration with 30 ml blocking buffer (50 mM Tris
Base pH 7.4, 0.15M NaCl, 0.25% (w/v) BSA, 0.05% Tween 20, 0.05 NaN3 and 2% fish skin gela-
tine, pre-filtered at 0.2 μm). Primary antibodies (mouse anti-Cathepsin L and rabbit anti-
HSP70) were diluted 1:1,000 in blocking buffer and rotated for 1h at RT inside SNAPid cas-
sette. After incubation, membranes were washed three times with PBS containing 0.1% (w/v)
Tween-20 (PBST) using SNAPid vacuum manifold. Anti-mouse green secondary antibody
was diluted 1:15,000 while anti-rabbit red secondary was diluted 1:20,000 in blocking buffer
and incubated with the membranes for 10 min at RT inside of SNAPid cassette. Membranes
were washed in PBST and scanned using Licor Odyssey system.
Supporting information
S1 Fig. Creation of the TbCMT1 conditional null mutant strategy. The strategy used to cre-
ate the TbCMT1 conditional null mutant from the Lister 427 BSF cell line is shown in (A). The
first allele TbCMT1was replaced with a PAC resistance cassette. An ectopic copy of tetracy-
cline-inducible TbCMT1with three C-terminal c-MYC tags was introduced into the rDNA
locus. TbCMT-MYC3 was under the control of a procyclin promoter regulated by two tet-oper-
ator (TetO) sequences. The selection was via a phleomycin resistance marker driven by a T7
promoter. After induction of the ectopic copy of TbCMT1-MYC3 with tetracycline, the second
TbCMT1 allele was replaced with an HYG resistance cassette. (B) Southern blot analysis of the
bloodstream form TbCMT1mutants. Genomic DNA (gDNA) was extracted from: lane 1, the
parental SM (TbCMT1+/+) cells; lane 2, heterozygous cells with one TbCMT1 allele replaced
with PAC and an ectopic tetracycline inducible copy of TbCMT1-MYC3 introduced
(TbCMT1-/+, TbCMT1Ti); and lane 3 the same cells following replacement of the second
TbCMT1 allele with HYG (TbCMT1-/-, TbCMT1Ti). Genomic DNA (gDNA) was digested with
PstI and XhoI. Diagrams indicate predicted gDNA fragments for the native TbCMT1 locus
before and after replacement with antibiotic resistance genes. Southern blots were hybridised
with a TbCMT1ORF probe (top panel), a PAC probe (middle panel), and a HYG probe (bot-
tom panel). Note: SM cell line carries a fragment of the HYG gene which weakly hybridises to
the HYG probe (lanes 1 and 2). When Wirtz and colleagues [17] generated the SM cell line, a
fragment of the hygromycin gene used to select for the TetR construct remained in the
genome. Consequently, an additional band is present at about 1.3 kb on the Southern blot
hybridised to the HYG probe (bottom panel).
(PDF)
S2 Fig. Southern blot analysis of TbCMT1 null mutant. gDNA was extracted from parental
SM (TbCMT1+/+) cells (lane 1), cells with one TbCMT1 allele replaced with PAC (TbCMT1-/+)
(lane 2), and cells following replacement of the second TbCMT1 allele with HYG (TbCMT1-/-)
(lane 3). gDNA was digested with PstI and XhoI. Diagrams indicate the predicted gDNA
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fragments for the native TbCMT1 locus before and after replacement with antibiotic resistance
genes. Southern blots were hybridised with TbCMT1ORF probe (top panel), PAC probe (mid-
dle panel), and HYG probe (bottom panel). When Wirtz and colleagues [17] generated the SM
cell line, a fragment of the hygromycin gene used to select for the TetR construct remained in
the genome. Consequently, an additional band is present at about 1.3 kb on the Southern blot
hybridised to the HYG probe (bottom panel).
(PDF)
S3 Fig. RNA-Seq biological replicate analyses. The correlations of the WT (A) and TbCMT1
null (B) biological replicates were visualised by scatter plot matrices using the log10 value of
the gene counts. Each matrix is composed of four rows and four columns to compare each bio-
logical replicate of wild type (WT1 to WT4) and TbCMT1 null (null-1 to null-4) samples with
each other. The diagonals of the matrices show the histograms of the log10 counts for each
sample. The lower parts of the matrices diagonal show the kernel density plots of each paired
sample, with the Pearson correlation coefficient reported in the top left corner of each paired
plot. The upper parts of the matrices show the scatter plots for each paired sample.
(PDF)
S4 Fig. Principal component analysis of the biological replicates. The gene expression vari-
ances between wild type (WT1 to WT4) and TbCMT1 null cells (null-1 to null-4) are displayed
as a principal component analysis (PCA) of scaled log2-transformed transcript counts. The
closer the points are in this two-dimensional space, the more similar the transcriptomes.
(PDF)
S5 Fig. Quantitative Western blot for Cathepsin-L. Representative Western blot analysis of
Cathepsin-L protein (red band) and HSP-70 protein (green band) in extracts of wild-type “sin-
gle marker” (SM) cells and three independent TbCMT1 null mutant clones (“double knock-
outs” null-1, null-2 and null-3). The positions of molecular weight markers are shown on the
left.
(PDF)
S1 Table. Differential gene expression analysis. The table reports the standard DESeq2 out-
put of the gene expression analysis. The Gene identification number (Gene Id), the gene
description (Gene Description), the DESeq2 baseMean counts (Base Mean), the log2 fold
change (log2 Fold Change) and the adjusted p-values (Adjusted pValue) are reported. Note:
The gene Tb10.v4.0040, located in a genome contig TP3F6-6f06.p1k, is identical in sequence
to TbCMT1 (Tb927.10.4500) and is presumably the same gene.
(XLSX)
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